DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS

In the present study an isocratic reverse phase-high performance liquid chromatography (RP-HPLC) method was developed and validated for simultaneous estimation of dicyclomine hydrochloride (DCY) and famotidine (FAM) in bulk and pharmaceutical dosage forms. The separation was achieved on a Phenomex G...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: DONDA,SHAILESH T, BAVISKAR,VISHAL B, DESHMUKH,PRASHANT K, BARI,SANJAY B, PATIL,PRAVIN O
Lenguaje:English
Publicado: Sociedad Chilena de Química 2014
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072014000400007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-97072014000400007
record_format dspace
spelling oai:scielo:S0717-970720140004000072015-01-09DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETSDONDA,SHAILESH TBAVISKAR,VISHAL BDESHMUKH,PRASHANT KBARI,SANJAY BPATIL,PRAVIN O Dicyclomine hydrochloride Famotidine RP-HPLC In the present study an isocratic reverse phase-high performance liquid chromatography (RP-HPLC) method was developed and validated for simultaneous estimation of dicyclomine hydrochloride (DCY) and famotidine (FAM) in bulk and pharmaceutical dosage forms. The separation was achieved on a Phenomex Gemini C column (4.6 x 250 mm, 5μ particle size) using a mixture of methanol and 0.1% triethylamine (TEA) pH 3.0 (adjusted with orthophosphoric acid) in the ratio of 40:60 (v/v) as a mobile phase. The flow rate was 1.0 mL min-1, column temperature was kept at 28 0 C and detection was monitored at 270 nm. The retention time of dicyclomine hydrochloride and famotidine was found to be 10.72 and 2.72 min respectively. Recovery studies were satisfactory and the correlation coefficient for FAM and DCY were 0.9947 and 0.9935 respectively, indicates linearity of the methods within the limits. The developed method can be used for routine quality control simultaneous analysis of DCY and FAM in tablet dosage form without any interference of excipients.info:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.59 n.4 20142014-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072014000400007en10.4067/S0717-97072014000400007
institution Scielo Chile
collection Scielo Chile
language English
topic Dicyclomine hydrochloride
Famotidine
RP-HPLC
spellingShingle Dicyclomine hydrochloride
Famotidine
RP-HPLC
DONDA,SHAILESH T
BAVISKAR,VISHAL B
DESHMUKH,PRASHANT K
BARI,SANJAY B
PATIL,PRAVIN O
DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
description In the present study an isocratic reverse phase-high performance liquid chromatography (RP-HPLC) method was developed and validated for simultaneous estimation of dicyclomine hydrochloride (DCY) and famotidine (FAM) in bulk and pharmaceutical dosage forms. The separation was achieved on a Phenomex Gemini C column (4.6 x 250 mm, 5μ particle size) using a mixture of methanol and 0.1% triethylamine (TEA) pH 3.0 (adjusted with orthophosphoric acid) in the ratio of 40:60 (v/v) as a mobile phase. The flow rate was 1.0 mL min-1, column temperature was kept at 28 0 C and detection was monitored at 270 nm. The retention time of dicyclomine hydrochloride and famotidine was found to be 10.72 and 2.72 min respectively. Recovery studies were satisfactory and the correlation coefficient for FAM and DCY were 0.9947 and 0.9935 respectively, indicates linearity of the methods within the limits. The developed method can be used for routine quality control simultaneous analysis of DCY and FAM in tablet dosage form without any interference of excipients.
author DONDA,SHAILESH T
BAVISKAR,VISHAL B
DESHMUKH,PRASHANT K
BARI,SANJAY B
PATIL,PRAVIN O
author_facet DONDA,SHAILESH T
BAVISKAR,VISHAL B
DESHMUKH,PRASHANT K
BARI,SANJAY B
PATIL,PRAVIN O
author_sort DONDA,SHAILESH T
title DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
title_short DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
title_full DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
title_fullStr DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
title_full_unstemmed DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
title_sort development and validation of a reversed-phase hplc method for the simultaneous estimation of dicyclomine hydrochloride and famotidine in bulk and tablets
publisher Sociedad Chilena de Química
publishDate 2014
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072014000400007
work_keys_str_mv AT dondashailesht developmentandvalidationofareversedphasehplcmethodforthesimultaneousestimationofdicyclominehydrochlorideandfamotidineinbulkandtablets
AT baviskarvishalb developmentandvalidationofareversedphasehplcmethodforthesimultaneousestimationofdicyclominehydrochlorideandfamotidineinbulkandtablets
AT deshmukhprashantk developmentandvalidationofareversedphasehplcmethodforthesimultaneousestimationofdicyclominehydrochlorideandfamotidineinbulkandtablets
AT barisanjayb developmentandvalidationofareversedphasehplcmethodforthesimultaneousestimationofdicyclominehydrochlorideandfamotidineinbulkandtablets
AT patilpravino developmentandvalidationofareversedphasehplcmethodforthesimultaneousestimationofdicyclominehydrochlorideandfamotidineinbulkandtablets
_version_ 1718445526005841920